510(k) Report

FDA product code · Hematology

Visual, Semi-Quant. (Colorimetric), Glucose-6-Phosphate Dehydrogenase

JMBClass II21 CFR 864.7360510(k) required1 decision since 19850 recalls

1 FDA decision since 1985. No recall names this code.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, hematology panel

Twenty years of JMB at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · JMB

FDA has decided no JMB device since 2007.

Median 510(k) review, days · JMB

Too few JMB 510(k)s in any year since 2007 to give a median.

Recalls per year · JMB

No recall names JMB since 2007.

Adverse event reports per year · JMB

No MAUDE report names JMB since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
FIG. 1 — JMB by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in JMB? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 864.7360.